Protegrin-1 enhances bacterial killing in thermally injured skin

Critical Care Medicine

Volumn 29, Issue 7, 2001, Pages 1431-1437

  Steinstraesser, Lars ^a   Klein, Richard D ^a   Aminlari, Alireza ^a   Fan, Ming Hui ^a   Khilanani, Vijay ^a   Remick, Daniel G ^a   Su, Grace L ^a   Wang, Stewart C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Animal; Antimicrobial peptides; Bacterial counts; Burn wound infection; Cathelicidins; Innate immunity; Multiple drug resistance; Protegrin; Pseudomonas aeruginosa; Radial diffusion assay; Rat; Silver sulphadiazine

Indexed keywords

ACETIC ACID; CATHELICIDIN; GENTAMICIN; PROTEGRIN; SULFADIAZINE SILVER;

ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BURN; COLONY FORMING UNIT; DIFFUSION; IMMERSION; MALE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; SEPSIS; SKIN INJURY; THERMAL INJURY; WOUND HEALING; WOUND INFECTION;

EID: 0034954221     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200107000-00022     Document Type: Article

References (35)

1. Infection in burn patients: The problems of pathogenesis, prevention and treatment
2. Control of pseudomonas infection in burns by silver sulfadiazine
3. The successful control of burn wound sepsis
4. Review of pseudomonas sepsis in thermal burns: Verdoglobin determination and gentamicin therapy
5. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
6. Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys
7. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci
8. Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries
9. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients
10. Structure-activity studies on magainins and other host defense peptides
11. Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides
12. Protegrins: Leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins
13. Identification of a new member of the protegrin family by cDNA cloning
14. The structure of porcine protegrin genes
15. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders
16. Antimicrobial peptides of phagocytes and epithelia
17. Localization and genomic organization of sheep antimicrobial peptide genes
18. Bactericidal activity of mammalian cathelicidin-derived peptides
19. The cathelicidin family of antimicrobial peptide precursors: A component of the oxygen-independent defense mechanisms of neutrophils
20. The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids
21. Protegrin-1: A broad-spectrum, rapidly microbicidal peptide with in vivo activity
22. Membrane thinning effect of the beta-sheet antimicrobial protegrin
23. Change in membrane permeability induced by protegrin 1: Implication of disulphide bridges for pore formation
24. Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations
25. Haemophilus ducreyi is susceptible to protegrin
26. Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory
27. Synthesis and solution structure of the antimicrobial peptide protegrin- 1
28. Calculation of a new Meeh constant and experimental determination of burn size
29. A standard animal burn
30. Staining of bacteria in tissue sections: A reliable Gram stain method
31. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa
32. Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha
33. The skin immune system: Progress in cutaneous biology
34. Peptide antibiotics and their role in innate immunity
35. Feasibility of biolistic gene therapy in burns